Novo Nordisk Inc. is a major pharmaceutical company. It lobbies Congress and federal agencies mainly on Medicare and Medicaid issues, especially coverage of anti-obesity medicines, and on drug supply chain transparency and integrity including compounding and counterfeit medicine concerns. The filings show four reports totaling $440,000 and list NVG, LLC as a hired firm.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ANDREA LARUE
The latest disclosures for this client.
NVG, LLC
Q1NVG, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
NVG, LLC
BONNIE HOGUE DUFFY
NVG, LLC
BRADY KING
NVG, LLC
IRENE BUENO
NVG, LLC
JULIO C. LAINEZ
NVG, LLC
mr JOSHUA F. HURVITZ
NVG, LLC
NVG, LLC
Q3NVG, LLC
Q2NVG, LLC
Q1